Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for RXRX. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 333 institutions reported holding RXRX, with 361.9 million shares worth $1.3 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Vanguard | 58,142,921 | $213M | INCREASED |
| BlackRock | 50,304,691 | $185M | INCREASED |
| ARK Invest | 41,337,632 | $152M | INCREASED |
| State Street | 34,706,130 | $127M | INCREASED |
| Baillie Gifford | 23,487,907 | $86M | DECREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Blake Borgeson (Director) | SELL | 40,000 | $155K | 2026-11-03 |
| Fred Hassan (Director) | AWARD | 156,658 | 2026-11-02 |
Full institutional holdings, insider history, and congressional trades for Recursion Pharmaceuticals, Inc. Class A Common Stock on SentiSense.